Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Boehringer Ingelheim
Cipla
Fish and Richardson
Harvard Business School
McKesson
Johnson and Johnson
Healthtrust
Cerilliant
AstraZeneca

Generated: February 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040792

« Back to Dashboard

NDA 040792 describes CARISOPRODOL, which is a drug marketed by Able, Accelrx Labs, Aurobindo Pharma, Epic Pharma Llc, Fosun Pharma, Hikma Intl Pharms, Ingenus Pharms Nj, Natco Pharma Ltd, Nostrum Labs Inc, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Vintage Pharms, Watson Labs, Watson Labs Teva, Wilshire Pharms Inc, Heritage Pharms Inc, and Novast Labs Ltd, and is included in thirty-one NDAs. It is available from fifty-three suppliers. Additional details are available on the CARISOPRODOL profile page.

The generic ingredient in CARISOPRODOL is aspirin; carisoprodol; codeine phosphate. There are twenty-one drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the aspirin; carisoprodol; codeine phosphate profile page.
Summary for 040792
Tradename:CARISOPRODOL
Applicant:Aurobindo Pharma
Ingredient:carisoprodol
Patents:0
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details
Pharmacology for NDA: 040792
Medical Subject Heading (MeSH) Categories for 040792
Suppliers and Packaging for NDA: 040792
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
CARISOPRODOL carisoprodol TABLET;ORAL 040792 ANDA Rising Pharmaceuticals, Inc. 64980-380 N 64980-380-01
CARISOPRODOL carisoprodol TABLET;ORAL 040792 ANDA Rising Pharmaceuticals, Inc. 64980-381 N 64980-381-50

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength350MG
Approval Date:Aug 6, 2009TE:AARLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength250MG
Approval Date:Nov 8, 2016TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Queensland Health
Daiichi Sankyo
Baxter
Fuji
Dow
Colorcon
Cerilliant
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot